ABSTRACT. Amiloride-sensitive potassium secretion in response to acute potassium loading is lower in the newborn than in the adult. Potassium secretion is a function of late distal tubule and cortical collecting tubule Na,K-ATPase activity. Na,K-ATPase activity in vivo is determined by enzyme abundance and catalytic turnover. Chronic potassium supplementation increases potassium secretory capacity in the adult by increasing enzyme abundance in the late distal and cortical collecting tubules. We hypothesized that the lower potassium secretory capacity of the newborn was the result of lower late distal and cortical collecting tubule Na,K-ATPase activity and could be similarly enhanced. To test this hypothesis, newborn dogs were supplemented with 6 mmol KC1.d-'. kg-' for 1 wk; agematched litter mate controls were not ( n = 8 pairs). Potassium supplementation resulted in a mean increase in V,,, Na,K-ATPase activity in vitro (proportional to pump abundance) of 70 + 42%. Mean Na,K-ATPase activities + S E M were 279 + 58 versus 198 2 44 nmol inorganic P.
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h-I-gg DNA-', p = 0.05. However, amiloride-sensitive potassium secretion after an acute potassium load of 20 pmol. min-'. kg-' over 150 min was not enhanced (9.6 +-1.8 versus 8.9 + 0.8 pmol . min-' .kg-', potassium-supplemented versus control animals). We conclude that lower enzyme abundance is not primarily responsible for the newborn's lower potassium secretory capacity. W e speculate that the factor that limits secretion in the newborn during acute potassium loading does so by restricting catalytic turnover of the enzyme in vivo. (Pediatr Res 30: 457-463,1991) Abbreviations KIl2, substrate concentration at which the reaction velocity is half maximum Na,K-ATPase, sodium-potassium-activated adenosine triphosphatase T ' H~~, free water reabsorption TFK, tubular fluid potassium concentration TTKG, transtubular potassium gradient is less than that of the mature nephron (1) . Transtubular potassium secretion in these nephron segments is driven by basolateral membrane Na,K-ATPase (2, 3). Na,K-ATPase activity has been shown to be lower in neonatal than adult nephron segments (4) (5) (6) . It is possible, therefore, that the potassium secretory response of the immature nephron may be limited by lower Na,K-ATPase activity.
Results of a study that examined the effect of increasing Na,KATPase activity on the renal response to acute potassium loading in newborn dogs did not support this possibility (7) . In that study, newborn dogs were subjected to chronic potassium supplementation for 1 to 3 wk after birth to enhance Na,K-ATPase activity in potassium secretory nephron segment(s). Chronic potassium supplementation doubled V,,, cortical Na,K-ATPase activity compared with controls (who received distilled water supplementation), but did not enhance urinary excretion of an acute potassium load in the newborn dog. These results were interpreted to indicate that Na,K-ATPase pump abundance is not rate limiting in excretion of a potassium load in the newborn. However, it is possible that water-loading the controls confounded the results by decreasing their cortical Na,K-ATPase activity or enhancing their renal response to acute potassium loading. Also, the design of that study did not allow potassium secretion to be estimated. Differences in potassium secretion may not be reflected in differences in potassium excretion (8, 9) .
Therefore, the present study was undertaken to test the hypothesis that the lower potassium secretory capacity of the immature distal nephron during acute potassium loading is the result of lower Na,K-ATPase activity. In contrast to the previous study, controls received no supplementation of any kind. In addition, the pyrazine diuretic amiloride was infused after acute potassium loading so that potassium secretion could be estimated (1) . The objectives of this study were to confirm that the results of the previous study could be reproduced, that water loading of the controls in the previous study did not account for those results, and that neither an increase in urinary potassium excretion nor an increase in tubular potassium secretion is associated with the enhanced V,,.,, cortical Na,K-ATPase activity in the newborn dog.
MATERIALS AND METHODS
Studies were performed in newborn mongrel dogs. The protocol conformed to the NZH Guide fbr the Care and Use of' The potassium secretory response of the amiloride-sensitive ~~b~~~~~~~ ~~i~~l~ and was approved by the ,,aboratory segments of the immature n e~h r o n to acute potassium loading (10) .
A gavage tube was passed twice daily in control animals, but no fluid was administered. All newborn dogs remained with and were suckled by their mother until the morning of the acute potassium loading experiment. Potassium loading: amiloride blockade. After the 7-d supplementation period, control and potassium-supplemented animals from littermate pairs were removed from their mother on the same or alternate days to determine renal function under baseline conditions and in the potassium-loaded state without and then with blockade of distal nephron potassium secretion by amiloride. Animals were anesthetized with 20-30 mg/kg of i.v. pentobarbital sodium. Rectal temperature was maintained at 37.9"C with a servo-controlled heat lamp and heated operating table. Animals were ventilated via a tracheostomy tube with a volume-controlled Harvard Rodent Ventilator (Harvard Apparatus Co. Inc., S. Natick, MA) and supplemental 02. Polyethylene catheters were placed in the left femoral vein for infusion of i.v. fluid and inulin, in each femoral artery for blood sampling and heart rate and blood pressure monitoring, and in each ureter for timed urine collections. All incisions were surgically closed.
After surgery, the ventilator was adjusted to maintain PCO, at 35-45 mm Hg (4.7-6.0 kPa). No further ventilator adjustments were subsequently made. A priming dose of [3H] inulin was given as a bolus followed by infusion of Isolyte P with 5% dextrose (Kendall-McGraw, Irvine, CA) and labeled inulin at a rate of 0.1 m L m i n -' . kg-' as a maintenance solution. After a I-h recovery and equilibration period, a 60-min baseline renal clearance was taken.
After this baseline clearance, an Isolyte Plinulin solution with KC1 added to a final concentration of 200 mM was substituted for the Isolyte P/inulin maintenance solution. This high potassium solution was infused continuously for 150 min at a rate of 0.1 mL. min-I -kg-' to provide 20 pmol KC1 . min-I .kg-'. All urine was collected during this infusion. After 120 min of KC1 loading, a 30-min clearance was taken. Renal function during this second clearance period represents function in the potassium-loaded state in the presence of distal potassium secretion. At the end of this second clearance period, the high potassium infusion was discontinued, 1.0 mg amiloridelkg given over 5 to 10 min, and Isolyte P with 5% dextrose solution with labeled inulin and amiloride infused at 0.1 mL. min-I. kg-' to provide 2.4 mg. h-' .kg-' of amiloride continuously. This resulted in a potassium infusion rate of 2 pmol . min-' .kg-' during amiloride blockade. The high potassium infusion was discontinued when amiloride was begun to prevent lethal hyperkalemia that would otherwise have resulted from amiloride blockade of potassium secretion. After 1 h for equilibration, another 30-min clearance was taken. In a previous study (I), this protocol resulted in stable plasma potassium concentration, acid-base status, and net potassium accumulated from the second to the third clearance periods. Renal function measured during this third clearance period represents function in the potassium-loaded state in the absence of distal potassium secretion.
The abdomen was reopened at the end of the third clearance period and one kidney removed, weighed, and flash frozen in liquid nitrogen within 30-45 s of ligation of the hilar vessels. Kidneys were subsequently stored at -70°C until they were dissected and assayed for Na,K-ATPase activity.
Bodyfluid analysis. and expressed in mL. min-' .kg body wt-I. Potassium excretion during the 150-min high potassium infusion was expressed as a fraction of the infused load. Potassium excretion during each of the three clearance periods was expressed in pmol . min-' . kg body wt-I. Amiloride-sensitive potassium secretion in the potassium-loaded state was estimated as the difference between urinary potassium excretion during the last 30 min of KC1 loading (clearance period 2) and potassium excretion during amiloride blockade after KC1 loading (clearance period 3). The TFK at the end of the potassium secretory nephron segments was calculated for each of the three clearance periods as the urine potassium concentration divided by the urine to plasma osmolality ratio (1 1, 12) . The TTKG at the same tubular site was calculated as the TFK divided by the plasma potassium concentration at the midpoint of the respective clearance period.
Na,K-ATPase analysis. Approximately 100-mg samples of cortex and outer medulla were dissected in iced saline from partially thawed transverse sections of kidney and homogenized separately in iced sucrose buffer. Homogenates were then flashfrozen in liquid nitrogen and thawed in ice, and aliquots were taken for Na,K-ATPase and DNA analysis. Na,K-ATPase activity was determined under V,,, conditions in duplicate samples from the ouabain-sensitive hydrolysis rate of 32P-r-ATP to inorganic 32P, as previously described (7). Na,KATPase activity measured under these conditions is proportional to the number of catalytically active enzyme units (13) . The DNA content of tissue homogenates was determined spectrophometrically after perchloric acid extraction and reaction with diphenylamine (14, 15) . Na,K-ATPase activity was expressed as nmol of 32P-r-ATP hydrolyzed per h per pg DNA and, thus, was proportional to V,,, enzyme activity per cell.
Duta analysis. Data are presented as means and SEM. A p value of less than or equal to 0.05 was considered significant. Statistical comparisons of single measures data between agematched control and potassium-supplemented littermate pairs were made using the paired t test when these data were normally distributed. The paired sample Wilcoxon signed rank test was used when they were not. Two-factor analysis of variance with repeated measures of one factor [between-within design (16)] was used to make comparisons between the two groups, among the three clearance periods. If the F ratio for the main effect of clearance period exceeded the critical Fo.95, then differences among pooled group means were examined using the NewmanKeuls test. If the F ratio for interaction effect exceeded the critical Fags, then differences among cell means were examined using the Newman-Keuls test.
RESULTS
Forty-one animals were randomly assigned to the control or potassium-supplemented groups. Two of 20 control and three of 21 KC1-supplemented animals did not survive the supplementation period or surgical preparation ( p = 0.52 by Fisher's exact test). Another seven of the control and eight of the potassiumsupplemented animals became anuric after 30-1 50 min of high potassium infusion ( x 2 = 0, p = 1.0). Three controls and two potassium-supplemented animals remained unmatched. Clearance studies were complete, therefore, in eight age-matched, littermate pairs. Renal clearance and biochemical data are presented for these eight pairs.
Potassium supplemenfation. Body weight and growth were not different between the groups at the start of, during, or at the end of the week-long supplemented period ( Table 1) . Baseline renal clearance data are presented in Table 2 and Figure 1 . Baseline data were obtained 14-18 h after the last gavage, 1 h after surgical $ Body wt at the beginning of the supplementation period. under pentobarbital anesthesia, and just before acute potassium loading.
t
Mean (SEM).
$ Paired sample Wilcoxon signed rank test.
3 Paired t test.
14, Fig. 1 . Urinary potassium excretion rates (top panel) and plasma potassium concentrations (bottom panel) in control and potassiumsupplemented newborn dogs during the first (baseline), second (potassium loaded), and third (potassium loaded with amiloride blockade of distal potassium secretion) clearance periods. Error bars depict SEM. Significance levels were calculated by the Newman-Keuls method after between-within analysis of variance showed a significant effect for clearance period. There was no significant main effect of supplementation or interaction effect on either potassium excretion or plasma potassium concentration.
preparation under pentobarbital anesthesia, and just before acute potassium loading. Baseline urine flow rate was significantly greater in controls, although there were no significant differences in GFR, urine or plasma osmolality, or urine osmolality to plasma osmolality ratio (Table 2 ). TCH20 tended to be lower in the potassium-supplemented animals ( p = 0.09). Baseline plasma potassium concentrations were similar (Fig. 1, bottom) . Although there were no significant experimental or interaction effects on urinary potassium excretion rate by analysis of variance, potassium excretion tended to be less in the potassium-supplemented animals under baseline conditions (Fig. I, top) . The significance level by paired t test was 0.03. However, there were no significant differences in TFK or in the TTKG in the potassium secretory nephron segments under baseline conditions (Fig. 2) .
Potassium loading. Control animals excreted 46 + 8% and potassium-supplemented animals excreted 39 + 4% of the acute potassium load during the 150-min infusion ( p = 0.45). Renal clearance data during the second clearance period (last 30 min of potassium loading) are presented in Table 3 and Figure 1 . Urine osmolality was lower in control than potassium-supplemented animals (p = 0.01), but the differences in urine flow rate and TCH20 observed under baseline conditions abated. Urinary potassium excretion rates (Fig. 1, top) increased similarly to rates Fig. 2 . The apparent tubular fluid potassium concentrations (1011 panel) and the transtubular potassium concentration gradients (hottorn punel) at the end of the potassium secretory nephron segment(s) for control and potassium supplemented newborn dogs at baseline and at the end of potassium loading. Error burs depict SEM. The significance level indicated was determined by between-withln analysis of variance. There was no significant main effect of supplementation on TFK or TTKG, no main effect of clearance period on TTKG, and no interaction effect on TFK or TTKG. 3-to 4-fold greater than baseline ( p < 0.0 1 by Newman-Keuls).
There was no difference between the groups in the absolute increase in potassium excretion from the first (baseline) to the second (potassium-loaded) clearance period. Plasma potassium concentration (Fig. 1, bottom) increased significantly, but similarly, in the control and potassium-supplemented groups over the course of the experiment from approximately 4.3 to 6.6 mM ( p < 0.01 by Newman-Keuls). Figure 2 shows the calculated TFK and TTKG at the end of the potassium secretory nephron segment(s) under baseline (clearance period 1) and potassium-loaded (clearance period 2) conditions. TFK increased significantly, but similarly, in control and potassium-supplemented animals from 55 to 84 mM (Fr1,141 = 13.7, p = 0.002) during the high potassium infusion. TTKG remained unchanged at approximately 13.
Potassium loading: amiloride blockade. As shown in the top panel of Figure 1 , blockade of amiloride-sensitive potassium secretion produced a marked, but similar, fall in potassium excretion in control and potassium-supplemented animals ( p < 0.0 1, clearance period 2 versus clearance period 3, by NewmanKeuls). Amiloride inhibited 90 + 2% of potassium excretion in controls and 89 + 2% in potassium-supplemented animals in the potassium-loaded state ( p = 0.63 by paired t test).
Plasma potassium concentration (Fig. 1 , bottom panel) tended to increase in both groups from the second to the third clearance periods from approximately 6.6 to 7 mM ( p > 0.05 NewmanKeuls). However, there were no significant differences in net potassium accumulated (calculated as the difference in cumulative potassium infused and cumulative potassium excreted) by the midpoints of the second and third clearance periods in either group. Controls accumulated 1.5 a 0.2 mmol/kg body wt by the second and 1.5 -+ 0.3 mmol/kg by the third clearance period. Potassium-supplemented animals accumulated 1.7 t-0.1 mmol/ kg by the second and 1.6 f 0.2 mmol/kg by the third clearance period. Arterial pH remained unchanged in both groups from the second to the third clearance periods. Amiloride-sensitive potassium secretion in the potassium-loaded state was 9.6 .+ 1.8 pmol.min-I .kg body wt-I in control animals and 8.9 & 0.8 pmol . min-I .kg body wt-' in potassium-supplemented animals, p = 0.77 by paired t test.
TFK during amiloride blockade in the potassium-loaded state (clearance period 3) are shown for each group along with the corresponding TTKG in Figure 3 . Neither TFK nor TTKG in the potassium-loaded state with amiloride blockade differed between the groups. Moreover, TTKG was not different from 1 for either group.
Na,K-ATPase activity. Cortical Na,K-ATPase activities under V,,, conditions are shown for each of the eight age-matched, littermate controls in Figure 4 . Enzyme activity was greater in the potassium-supplemented member of six of the eight pairs after 1 wk of supplementation. Mean Na,K-ATPase activities were 198 + 44 and 279 + 58 nmol inorganic P liberated. h-' . pg DNA-' in control and potassium-supplemented newborn dogs, respectively ( p = 0.05 by paired t test). The mean increase in Na,K-ATPase activity after 1 wk of potassium supplementation was 70%.
Outer medullary activity under V,,, conditions was 166 + 16 and 155 +-32 nmol inorganic P liberated. h-'.pg DNA-' in control and potassium-supplemented dogs, respectively ( p = 0.74 by paired t test). DISCUSSION urinary potassium excretion is largely the result of amiloridesensitive potassium secretion and that the cellular mechanisms Chronic potassium supplementation of newborn dogs for I wk of potassium excretion are similar to those in the adult. resulted in an average increase in cortical Na,K-ATPase activity,
The validity of the former conclusion depends upon the reliunder V, , , conditions, of 70% over that in controls. However, ability of the method used to determine amiloride-sensitive pothis increase in pump abundance did not blunt the development tassium secretion. This calculation assumes that the effect of of hyperkalemia during acute potassium loading and did not amiloride, at the dose used, is limited to the potassium secretory enhance urinary potassium excretion or increase the TTKG in nephron segment and that the decrement in potassium excretion potassium secretory nephron segment(s) under.baseline condi-with amiloride infusion is the result of pharmacologic blockade tions or during acute potassium loading. Moreover, there was no and not the discontinuation of the high potassium infusion. The difference in amiloride-sensitive potassium secretion between data supporting these assumptions have been previously reviewed (1, 34) and support the assertion that this method provides a control and potassium-supplemented animals. Even if the two reasonable estimate of amiloride-sensitive potassium secretion. littermate pairs in which Na,K-ATPase activity in the control 1, addition, the TTKG of approximately unity during amiloride exceeded that in the ~otassium-su~~lemented animal are ex-blockade in both control and potassium-supplemented groups cluded from the analysis, no effect of chronic supplementation indicates that amiloride blocks essentially all active potassium or enhanced Na,K-ATPase activity could be demonstrated in secretion in the potassium-loaded state (I I, 12). response to acute potassium loading. These results substantiate
The conclusion that the cellular mechanism of potassium those of our previous study and support a lack of effect of secretion is similar in the newborn and adult is based upon the increased pump abundance on amilo,.ide-sensitive potassium mechanism of action of amiloride at the cellular level. Amiloride secretion as well as on urinary potassium excretion in the new-selectively blocks the luminal membrane sodium conductance channel in potassium secretory cells (35 36 ) Thus, the nearborn dog. Moreover, they eliminate water loading in controls as complete inhibition of potassium by amiloride in the a confounding variable in our previous study.
newborn implies that potassium eMux from potassium secretory These results are best interpreted in light of what is known cells is coupled to transluminal membrane sodium influx. about renal potassium handling in theadult. Potassium transport
We have not directly confirmed that the increase in renal in late distal and collecting tubules largely determines urinary cortical Na,K-ATPase associated with chronic potassium loading potassium excretion in the adult (17) . Transcellular potassium occurs in the potassium secretory nephron segments. However, secretion and sodium reabsorption are coupled and directly chronic potassium supplementation has not been reported to linked to the active, electrogenic exchange of sodium and potas-increase Na,K-ATPase activity in any other cortical n e~h r o n sium across the basolateral membranes of connecting tubule cells Segments in adult animals (1 8, 20, 25, 26) . 1t is ~ossible that the and principal cells in these nephron segments 8-2 ). Basolat-magnitude of the increase in Na,K-ATPase activity with chronic potassium supplementation of the newborn dog is not sufficient era1 membrane Na,K-ATPase generates the electrochemical gra-to produce a detectable increase in potassium secretion. This dients that permit the passive exchange of sodium and potassium seems unlikely, however, because in chronically potassium-supacross the luminal membranes. Factors that alter potassium plemented adult animals the percentage of increase in urinary secretion may do so by affecting basolateral membrane Na-K potassium excretion is greater than or equal to the associated pump abundance or turnover rate or luminal membrane Na-K percentage of increase in segmental Na,K-ATPase activity (25, flux (22, 23) . Dietary potassium supplementation enhances distal 29). Moreover, if chronic potassium supplementation of the n e~h r o n Dotassium secretion and urinam Dotassium excretion newborn dog increases Na,K-ATPase activity in potassium seunder baseline conditions (9, 2 1, 24-3 1) as &ell as during potassium loading (9, 10, (27) (28) (29) (30) (31) . This enhanced secretory capacity is at first the result of an increase in Na-K pump turnover rate without a change in pump number (23, 28) . With continued supplementation, basolateral pump number increases and pump turnover rate returns to baseline, so that the enhanced potassium secretory capacity is maintained by increased pump abundance alone (28, 32) . Electron microprobe analysis of intracellular sodium and potassium activities in connecting tubule and principal cells from chronically potassium-supplemented rats has shown that enhanced sodium reabsorption and potassium secretion in these nephron segments is associated with decreases in cell sodium activity without marked increases in cell potassium activity (24) . Because increased Na,K-ATPase activity results in increased sodium extrusion and potassium uptake at the basolateral membrane, these findings imply that luminal membrane potassium, and perhaps sodium, conductance or passive driving forces must increase with chronic potassium loading (24, 33) . It is not known which, if any, of the factors that affect the ion conductance or passive driving forces across the luminal membranes of connecting tubule and principal cells is responsible for this increase in apical sodium and/or potassium flux with chronic potassium loading.
The findings of this and our previous study of the effects of chronic potassium supplementation in newborn dogs are thus cretory nephron segments only (and not in the proximal convoluted tubule, for example) then whole cortex enzyme activity would underestimate the percentage of increase in these nephron segments (25, 37) .
We conclude, therefore, that in the newborn I ) potassium secretory/excretory capacity is closely linked to Na,K-ATPase activity in amiloride-sensitive potassium secretory nephron segments; 2) dietary potassium supplementation increases cortical V,,, Na,K-ATPase activity, most likely in potassium secretory nephron segments; 3) the magnitude of the increase in V,,, Na,K-ATPase activity would be expected to be physiologically significant by adult standards; and 4) this increase in V,,, Na,KATPase does not enhance potassium secretory capacity. These paradoxical conclusions can be reconciled by considering the relationship between V,,, Na,K-ATPase activity in vitro and pump activity in vivo.
V,,, activity represents the maximum hydrolytic activity of all available enzyme units (22) and is thus proportional to pump abundance. In the intact cell, Na,K-ATPase activity is a function of both pump abundance and catalytic turnover rate of individual pump units (28) . Under physiologic conditions, intracellular sodium activity or the intracellular Na:K ratio regulates enzyme turnover rate.' An increase in intracellular sodium activity or I Strictly speaking, the catalytic turnover rate is a function of the kinetic properties of the enzyme, as well as of intracellular sodium activity or the Na:K ratio. However, chronic dietary potassium supplementation has little or no effect on the kinetic properties of the stimulated enzyme in the adult animal (32) . To evaluate this in the newborn dog, kinetic curves for sodium and potassium were different from what has been shown in the adult. Therefore, this generated in cortical and outer medullary tissue samples from three control and discrepancy might be explained by consideration of what is two potassium-supplemented animals. There were no differences in the K,, for either substrate between experimental groups. The apparent K,, for sodium in and differences in potassium cortex was 20.9 f I. I mM in supplemented and 21.5 + 1.3 mM in control animals.
handling between the newborn and adult.
The K,, for sodium in outer medulla was 17.5 f 2.2 mM in supplemented and
The present and previous studies of the effect of amiloride on 18.3 f 2.8 mM in control animals. The Kt, for potassium in cortex was 2.3 f 0.09 urinary potassium excretion (1, 34) confirm that amiloride aland 2.2 f 0.07 mM in potassium-supplemented and control animals, respectively. These differences were not statistically significant. These data, therefore, confirm inhibits potassium in that chronic dietary potassium supplementation does not alter the kinetic properties the newborn and adult dog. This indicates that, in the newborn, of the enzyme in the immature kidney.
Na:K ratio stimulates pump turnover; a decrease inhibits pump turnover. Under baseline conditions, pump turnover rate is limited to less than 10% of maximum in connecting tubule and principal cells and is very sensitive to small changes in cytoplasmic sodium activity or Na:K ratio (24, 38, 39) . Therefore, in vitro V,,,, Na,K-ATPase activity (pump abundance) does not strictly regulate potassium secretion, even in the adult. Actual in vivo Na,K-ATPase activity in potassium-secreting cells is the critical factor (28). As noted above, Na,K-ATPase activity in vivo is a function of pump abundance and pump turnover rate. Therefore, we propose that restriction of pump turnover rate is the explanation for the failure of the increase in pump abundance to produce an increase in potassium secretory capacity in the newborn. This restricted Na-K pump turnover rate might well be the result of failure of the luminal membrane sodium and/or potassium conductances, or the passive transmembrane driving forces, to increase. If one or the other of these failed to increase with chronic potassium loading along with basolateral membrane pump abundance in connecting tubule and principal cells [as it apparently does in the adult (40)], then the resulting increase in Na,K-ATPase activity would lower cytoplasmic sodium activity and/or raise cytoplasmic potassium activity. Consequently, lower Na:K cytoplasmic ratio would itself restrict pump turnover rate in vivo (39) . Thus, in vivo, Na,KATPase activity and potassium secretory capacity might remain unchanged, or even decrease, compared with controls despite an increase in pump abundance. Indeed, the lower baseline urinary potassium excretion rate in the potassium-supplemented animals compared with controls suggests that in vivo Na,K-ATPase activity in the potassium secretory nephron segments may actually have been lower in the former group. This difference in potassium excretion is not likely to be spurious, inasmuch as the rates of urinary potassium excretion were identical in each group to those in our previous study (7) . In this regard, the basal urine flow rates in this study suggest a possible explanation for the failure of Na-K exchange across luminal membranes to increase. Adult animals invariably increase their urine flow rates after potassium supplementation (24, 25, 29-3 1, 4 1). Balance studies have shown this to be the result of increased free water intake (25, (28) (29) (30) 41) . Fujii et al. (28) have speculated that this enhanced urine flow facilitates excretion of the chronic potassium load. In the present study, basal urine flow rate was significantly lower in potassium-supplemented animals. Urine flow rates in each group were almost identical in our previous study (7) . Although no balance data could be obtained, this difference from the adult is probably the result of the lack of a source of free water in the suckling, potassium-supplemented newborn dogs. It also suggests that chronic high potassium intake per se decreases urine output if free water intake is not increased. Although urine flow rate does not necessarily parallel distal tubule fluid flow rate, lower TCH20 without a lower urine to plasma osmolality ratio in the potassium-supplemented versus the control group indicates that the tubular fluid flow rate out of the proximal tubule was lower in the potassium-supplemented group under baseline conditions. A lower luminal sodium concentration and perhaps fluid flow rate into the distal tubule from the loop of Henle would be expected as a result. These factors depress potassium secretion in the late distal and cortical collecting tubules (3, 42) . We speculate, therefore, that in potassiumsupplemented animals potassium excretion may be lower under baseline conditions despite increased Na,K-ATPase pump abundance because distal fluid flow rate and sodium concentration are lower than in controls. The differences in potassium excretion rates, in urine flow rate, and TCHzo did not persist during acute potassium loading. Thus, differences in distal fluid flow rate and sodium concentration and Na-K pump turnover rate may abate somewhat during acute potassium loading. However, the turnover rate of the greater number of pumps in the potassiumsupplemented group may remain lower than that of controls, so that potassium secretion is similar.
The possibility cannot be excluded that the failure to demonstrate an increased potassium secretory capacity after chronic potassium loading was the result of failure of the latter to produce an increase in outer medullary Na,K-ATPase activity in this experimental model. Heterogeneity of responsiveness to chronic potassium loading appears to exist in different collecting tubule segments (25) (26) (27) 41) . There is one study that suggests that an increase in outer medullary Na,K-ATPase is necessary for potassium adaptation in the rat. This does not appear to be the case in the rabbit (26) . No information is available in the dog.
In summary, chronic potassium loading for 1 wk resulted in a 70% increase in cortical homogenate V,,, Na,K-ATPase activity in the newborn dogs. Assuming this process to be analogous to that in the adult, this increase is indicative of an increase in basolateral membrane pump abundance in connecting tubule and/or principle cells of the potassium secretory nephron segments and would be expected to increase potassium secretory capacity. However, this increase in pump abundance did not increase the calculated TFK or TTKG in the potassium secretory nephron segments, amiloride-sensitive potassium secretion, or urinary potassium excretion. These results are inconsistent with the hypothesis that the lower potassium secretory capacity of the newborn compared with that of the adult is the result of lower pump abundance in the potassium secretory nephron segments. We propose that both the lower potassium secretory capacity of the newborn during acute potassium loading and the failure of chronic potassium supplementation to enhance secretory capacity are the result of limitation of Na,K-ATPase turnover rate in vivo. We speculate that in the latter case, this restricted turnover rate may be the result of lower passive driving forces for the Na-K exchange across the luminal membrane as a consequence of lower sodium concentration in and/or water delivery to the potassium secretory nephron segments.
